Erschienen in:
01.12.2009 | Case Report
Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID
verfasst von:
Neslihan Edeer Karaca, Guzide Aksu, Ferah Genel, Nesrin Gulez, Sema Can, Yesim Aydinok, Serap Aksoylar, Emin Karaca, Imren Altuglu, Necil Kutukculer
Erschienen in:
Clinical and Experimental Medicine
|
Ausgabe 4/2009
Einloggen, um Zugang zu erhalten
Abstract
Severe combined immunodeficiencies (SCID) comprise a spectrum of genetic defects that involve both humoral and cellular immunities. Defects in recombinating activating gene 1 (RAG1), RAG2, Artemis, or LIG4 can disrupt V(D)J recombination. Defective V(D)J recombination of the T and B cell receptors is responsible for T−B−NK+SCID. Amorphic mutations in RAG1 and RAG2 cause T−B−NK+SCID, whereas hypomorphic mutations cause an immunodeficency characterized by oligoclonal expansion of TCRγδ T cells, severe CMV infection and autoimmunity. First patient is a typical T−B−NK+SCID with clinical and immunologic findings while the second is atypical with normal immunoglobulin levels, CD4 lymphopenia, elevated TCRγδ T cells, persistent CMV infection, and autoimmune hemolytic anemia. These cases are presented to emphasize that mutations in RAG1 gene may lead to a diverse spectrum of clinical and immunologic findings while hypomorphic mutations may be related with autoimmunity and refractory CMV infection during infancy.